BCTX BriaCell Therapeutics Corp Earnings per share for the last twelve months

Official company branding of BriaCell Therapeutics Corp. (BCTX)

BriaCell Therapeutics (BCTX) strives to create eco-safe breast cancer treatments while adhering to bioethics. This 12-month net income per share chart illustrates the progress in implementing this strategy, where the -9.33 level captures fresh values. However, business stability is constrained by a dependence on insurance payouts and fierce competition for capital among major specialized investors.

BCTX (BriaCell Therapeutics) Net earnings per one share for the last twelve months history from 07/04/2022 to 11/15/2026

BriaCell Corp - analytical breakdowns and key metrics (BCTX)

- current quotes and average value forecast:
Price Chart BriaCell Corp|BCTX - Average Forecast Price
- market capitalization data:
Market Value BriaCell Corp|BCTX - Real Price to Acquire Entire Company
- shareholders' equity book value data:
Book Value per Share BriaCell|BCTX - Total Stockholders' Equity|Market Value to Book Value Ratio briacell.com|BCTX - Total Business Assets
- debt and liquidity data:
Total Debt to Capital BriaCell Therapeutics|BCTX - Long-Term Debt to Equity|Short-Term Debt to Equity BriaCell Therapeutics|BCTX - Aggregate Debt Obligations|Debts to Book Capitalization BriaCell|BCTX - Long-Term Debt Volume|Company Short-Term Debts BriaCell|Quick Ratio briacell.com
- net income and valuation multiples indicators:
BCTX - Net Income|Projected Future Earnings BriaCell Therapeutics|BCTX - Market Cap to Earnings|Future Price to Earnings BriaCell Therapeutics Corp|BCTX - Price/Earnings to Growth Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization BriaCell Therapeutics Corp|BCTX - Profit before payment of interest, taxes and amortization|Net earnings per share for the last 12 months BriaCell|BCTX - Earnings per share for the trailing year|Year-over-year net earnings per share growth for the last 12 months briacell.com|BCTX - Net earnings per one share growth for the current year|Earnings growth forecast for next year BriaCell Therapeutics
- revenue and sales proceeds data:
BCTX - Company Sales Revenue|Projected Sales Volume BriaCell Corp|BCTX - Price to Sales|Price-to-Projected Revenue Ratio BriaCell Corp|BCTX - Revenue Dynamics YoY (Last Twelve Months)
General company analysis:BriaCell Therapeutics Corp. (BCTX)
Manufactured products of BriaCell Therapeutics Corp

Seeking a balance between asset quality and valuation, investors utilize EPS as a measure of earnings per share. This metric is calculated by dividing total annual net income by the number of outstanding securities. For BriaCell Therapeutics (BCTX), whose expenses are concentrated on clinical R&D and bio-waste disposal, this metric reflects the efficiency of its capital burn. Analyzing the current trailing 12-month EPS allows for the timely detection of business stagnation.

Competitors of BriaCell Therapeutics

MRUS - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Immutep Ltd|Anixa Bio (ANIX) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months Atossa|CNTX (Context Therapeutics Inc) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months mersana.com MRSN|Earnings per share for the last twelve months ESSA Pharma Inc (EPIX)|QT Imaging Holdings Inc. (QTI) - Net earnings per share for the trailing year